Related content

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

By Blumsohn A.   Marin F.   Nickelsen T.   Brixen K.   Sigurdsson G.   González de la Vera J.   Boonen S.   Liu-Léage S.   Barker C.   Eastell R.  

Osteoporosis International, Vol. 22, Iss. 6, 2011-06 ,pp. : 1935-1946

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of Biochemical Markers of Bone Turnover and Bone Mineral Density Between Hip Fracture and Vertebral Fracture

By Takahashi Masaaki   Naitou Kenichi   Ohishi Tsuyoshi   Nagano Akira  

Journal of Clinical Densitometry, Vol. 6, Iss. 3, 2003-09 ,pp. : 211-218

Humana Press, Inc

Access to resources Recommend Favorite

Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial

By Sugimoto Toshitsugu   Shiraki Masataka   Nakano Tetsuo   Kishimoto Hideaki   Ito Masako   Fukunaga Masao   Hagino Hiroshi   Sone Teruki   Kuroda Tatsuhiko   Nakamura Toshitaka  

Current Medical Research and Opinion, Vol. 29, Iss. 3, 2013-03 ,pp. : 195-203

Informa Healthcare

Access to resources Recommend Favorite

Relationship Between Changes in Bone Mineral Density and Vertebral Fracture Risk Associated With Risedronate: Greater Increases in Bone Mineral Density Do Not Relate to Greater Decreases in Fracture Risk

By Watts Nelson B.   Cooper Cyrus   Lindsay Robert   Eastell Richard   Manhart Michael D.   Barton Ian P.   van Staa Tjeerd-Pieter   Adachi Jonathan D.  

Journal of Clinical Densitometry, Vol. 7, Iss. 3, 2004-09 ,pp. : 255-261

Humana Press, Inc

Access to resources Recommend Favorite

Changes in Bone Turnover, Bone Mineral and Fracture Risk Induced by Drugs Used to Treat Epilepsy

By  

Current Drug Safety, Vol. 3, Iss. 3, 2008-09 ,pp. : 168-172

Bentham Science Publishers

Access to resources Recommend Favorite